Insulet Corp.

Insulet Corp.

PODD
Insulet Corp.US flagNASDAQ
165.35
USD
-0.33
- -
11.45BMarket Cap

Total Valuation

Insulet Corp. carries a market capitalization of 11.45B, placing it among publicly traded companies globally. Its enterprise value stands at 15.00B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap11.45B
Enterprise Value15.00B

Share Statistics

Insulet Corp. currently has 69.26M shares outstanding.

Shares Outstanding69.26M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Insulet Corp. trades at a trailing price-to-earnings ratio of 48.70. The price-to-sales ratio is 5.08, and the price-to-book ratio stands at 11.16.

PE Ratio48.70
PS Ratio5.08
PB Ratio11.16
P/TBV Ratio12.80
P/FCF Ratio22.87
P/OCF Ratio23.81

Enterprise Valuation

On an enterprise value basis, Insulet Corp. trades at an EV/EBITDA multiple of 24.91 and an EV/FCF ratio of 21.56. The EV/Sales ratio of 5.17 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 29.57 provides insight into valuation relative to core operating earnings.

EV / Sales5.17
EV / EBITDA24.91
EV / EBIT29.57
EV / FCF21.56

Financial Position

Insulet Corp. maintains a current ratio of 2.49, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 72.79, indicating elevated leverage, while an interest coverage ratio of 9.29 demonstrates adequate ability to service its debt obligations.

Current Ratio2.49
Quick Ratio1.49
Debt / Equity72.79
Debt / EBITDA1.57
Interest Coverage9.29

Financial Efficiency

Insulet Corp. posts a return on equity of 23.00 and a return on invested capital of 14.40.

Return on Equity (ROE)23.00
Return on Assets (ROA)9.31
Return on Invested Capital (ROIC)14.40
Return on Capital Employed (ROCE)13.32
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.86

Taxes

Over the trailing twelve months, Insulet Corp. has paid 101.50M in income taxes, reflecting an effective tax rate of 25.10.

Income Tax101.50M
Effective Tax Rate25.10

Stock Price Statistics

Insulet Corp.'s stock has declined approximately -41.96413% over the past 52 weeks. The 50-day moving average sits at 155.32, while the 200-day moving average is 232.15.

Beta (5Y)N/A
52-Week Price Change-41.96413%
50-Day Moving Average155.32
200-Day Moving Average232.15
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Insulet Corp. generated 2.90B in revenue and converted that into 302.80M in net income, yielding earnings per share of 4.29. EBITDA reached 602.20M, while operating income came in at 507.30M.

Revenue2.90B
Gross Profit2.06B
Operating Income507.30M
Pretax Income404.40M
Net Income302.80M
EBITDA602.20M
EBIT507.30M
Earnings Per Share (EPS)4.29

Balance Sheet

Insulet Corp. holds 480.40M in cash and equivalents against 948.10M in total debt, resulting in a net debt position of 467.70M. Total book value stands at 1.30B, with working capital of 1.02B providing operational flexibility.

Cash & Cash Equivalents480.40M
Total Debt948.10M
Net Debt467.70M
Equity (Book Value)1.30B
Book Value Per Share18.81
Working Capital1.02B

Cash Flow

Insulet Corp. produced 619.30M in operating cash flow over the past twelve months. After subtracting -27.90M in capital expenditures, free cash flow totaled 591.40M - equivalent to 8.42 per share.

Operating Cash Flow619.30M
Capital Expenditures-27.90M
Free Cash Flow591.40M
FCF Per Share8.42

Margins

Insulet Corp. operates with a gross margin of 71.01, reflecting its pricing power and cost economics. The operating margin of 17.49 and net profit margin of 10.44 provide insight into operational efficiency.

Gross Margin71.01
Operating Margin17.49
Pretax Margin13.94
Profit Margin10.44
EBITDA Margin20.76

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield8.21
FCF Yield4.37

Scores

Insulet Corp. posts an Altman Z-Score of 7.42, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score7.42